Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP914181.RAxcjlNvI5xJrQcu2V-KsEzP0J7_Nj95-4w_j2rbX_aag130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP914181.RAxcjlNvI5xJrQcu2V-KsEzP0J7_Nj95-4w_j2rbX_aag130_assertion type Assertion NP914181.RAxcjlNvI5xJrQcu2V-KsEzP0J7_Nj95-4w_j2rbX_aag130_head.
- NP914181.RAxcjlNvI5xJrQcu2V-KsEzP0J7_Nj95-4w_j2rbX_aag130_assertion description "[A total of 149 patients with multiple myeloma (MM) who received allogeneic hematopoietic stem cell transplantation (allo-HCT) with myeloablative (MAC; n = 38) or reduced-intensity conditioning (RIC; n = 110) regimens at MD Anderson Cancer Center were evaluated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP914181.RAxcjlNvI5xJrQcu2V-KsEzP0J7_Nj95-4w_j2rbX_aag130_provenance.
- NP914181.RAxcjlNvI5xJrQcu2V-KsEzP0J7_Nj95-4w_j2rbX_aag130_assertion evidence source_evidence_literature NP914181.RAxcjlNvI5xJrQcu2V-KsEzP0J7_Nj95-4w_j2rbX_aag130_provenance.
- NP914181.RAxcjlNvI5xJrQcu2V-KsEzP0J7_Nj95-4w_j2rbX_aag130_assertion SIO_000772 22231283 NP914181.RAxcjlNvI5xJrQcu2V-KsEzP0J7_Nj95-4w_j2rbX_aag130_provenance.
- NP914181.RAxcjlNvI5xJrQcu2V-KsEzP0J7_Nj95-4w_j2rbX_aag130_assertion wasDerivedFrom befree-20140225 NP914181.RAxcjlNvI5xJrQcu2V-KsEzP0J7_Nj95-4w_j2rbX_aag130_provenance.
- NP914181.RAxcjlNvI5xJrQcu2V-KsEzP0J7_Nj95-4w_j2rbX_aag130_assertion wasGeneratedBy ECO_0000203 NP914181.RAxcjlNvI5xJrQcu2V-KsEzP0J7_Nj95-4w_j2rbX_aag130_provenance.